Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „Cresemba“
Suchtreffer
Begriffe & Kennungen
Cresemba · 4.5 · Isavuconazole drug concentrations may significantly decrease.
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a mild CYP2B6 inducer; co-administration of isavuconazole may result in decreased plasma conc
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a mild CYP2B6 inducer; co-administration of isavuconazole may result in decreased plasma conc
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a mild inhibitor of P-glycoprotein (P-gp); co-administration with isavuconazole may result in
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a mild inhibitor of P-glycoprotein (P-gp); co-administration with isavuconazole may result in
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a mild inhibitor of UGT. Co-administration of isavuconazole with medicinal products which are
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a mild inhibitor of UGT. Co-administration of isavuconazole with medicinal products which are
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a mild inhibitor of the organic cation transporter 2 (OCT2). Co-administration of isavuconazo
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a mild inhibitor of the organic cation transporter 2 (OCT2). Co-administration of isavuconazo
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a moderate inhibitor of CYP3A4/5; co-administration of isavuconazole with medicinal products
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a moderate inhibitor of CYP3A4/5; co-administration of isavuconazole with medicinal products
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a substrate of CYP3A4 and CYP3A5 (see section 5.2). Co-administration of medicinal products w
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a substrate of CYP3A4 and CYP3A5 (see section 5.2). Co-administration of medicinal products w
Eintrag öffnenCresemba · 4.5 · Isavuconazole is an inhibitor in vitro of BCRP, and plasma concentrations of substrates of BCRP may therefore
Eintrag öffnenCresemba · 4.5 · Isavuconazole is an inhibitor in vitro of BCRP, and plasma concentrations of substrates of BCRP may therefore
Eintrag öffnenCresemba · 4.5 · Medicinal products metabolised by CYP2B6
Eintrag öffnenCresemba · 4.5 · Medicinal products metabolised by CYP2B6
Eintrag öffnenCresemba · 4.5 · Medicinal products metabolised by CYP3A4/5
Eintrag öffnenCresemba · 4.5 · Medicinal products metabolised by CYP3A4/5
Eintrag öffnenCresemba · 4.5 · Medicinal products renally excreted via transport proteins
Eintrag öffnen